(Q47734151)

5 February 2018

title

Diagnosis: Novel molecular signatures for adrenocortical carcinoma (English)

1 reference

5 February 2018

author

Felix Beuschlein

series ordinal

2

1 reference

5 February 2018

Matthias J Betz

object named as

Matthias J Betz

series ordinal

1

0 references

publication date

1 June 2009

1 reference

5 February 2018

Nature Reviews Endocrinology

published in

1 reference

5 February 2018

volume

5

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

297-299

1 reference

5 February 2018

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

Clinical review: Adrenocortical carcinoma: clinical update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

Pathological and molecular features of adrenocortical carcinoma: an update.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.93

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2009.93

1 reference

5 February 2018

Dimensions Publication ID

1007455523

0 references

1 reference

5 February 2018